|
2024
|
Invention
|
Use of anti-interleukin-11 antibody in preparation of drug for treating tumors. Provided is the u... |
|
|
Invention
|
Pharmaceutical composition containing anti-nectin4 antibody-drug conjugate and anti-pd-1 antibody... |
|
|
Invention
|
Nucleic acid encoding atp7b, adeno-associated virus vector and use thereof in preparing drug for ... |
|
|
Invention
|
Method for preparing antibody-drug conjugate. The present invention relates to a method for prepa... |
|
|
Invention
|
Antibody binding to nectin-4 and use thereof. Provided are an antibody and an antigen-binding fra... |
|
|
Invention
|
Anti-b7-h3 antibody or fragment thereof, and antibody drug conjugate targeting b7-h3. A series of... |
|
|
P/S
|
Retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wh... |
|
|
P/S
|
Wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies;... |
|
|
Invention
|
Method for treating ocular fundus vascular lesions by using anti-vegf antibody. Provided are an a... |
|
2023
|
Invention
|
Frα-targeting antibody or antigen-binding fragment thereof, and use thereof. Provided are an anti... |
|
|
Invention
|
Preparation containing anti-nectin-4 antibody drug conjugate and use thereof. The present inventi... |
|
|
Invention
|
Anti-human cd24 antibody and use thereof. Provided in the present invention are an anti-human CD2... |
|
|
Invention
|
Liquid antibody composition and use thereof. Disclosed in the present invention are a liquid anti... |
|
|
Invention
|
Anti-interleukin-11 antibody and use thereof. Disclosed is an anti-interleukin 11 (IL-11) antibod... |
|
|
Invention
|
Tumor combination therapy using anti-il-11 antibody. The present invention provides a drug combin... |
|
2022
|
Invention
|
Camptothecin compound and conjugate thereof.
Provided is a camptothecin compound, which is a com... |
|
|
Invention
|
Camptothecin compound and conjugate thereof. Provided is a camptothecin compound, which is a comp... |
|
|
Invention
|
Method for synthesizing 5,8-diamino-3,4-dihydro-2h-1-naphthalenone and intermediate compound used... |
|
|
Invention
|
Anti-suppression of tumorigenicity 2 antibody and liquid composition containing same. An anti-sup... |
|
|
Invention
|
Pharmaceutical use of anti-tumor inhibin 2 antibody. Provided is the use of a new anti-tumor inhi... |
|
|
Invention
|
New type bispecific antibody targeting lag-3 and pd-l1 and use thereof. A bispecific molecule tar... |
|
|
Invention
|
Anti-pd-l1 single-domain antibody and derivative protein thereof. Provided are a single-domain an... |
|
|
Invention
|
Antibody drug conjugate targeting nectin 4 and preparation method therefor and use thereof.
An a... |
|
|
Invention
|
Antibody-drug conjugate targeting nectin-4 and preparation method therefor and use thereof. An an... |
|
|
Invention
|
Antibodies binding lag-3 and use thereof. Provided are antibodies and antibody fragments specific... |
|
2021
|
P/S
|
Preparations for destroying noxious animals; dressings,
medical; dental abrasives; biochemical d... |
|
|
P/S
|
Biochemical drug; medicines for human purposes; biological
preparations for medical purposes; ph... |
|
|
Invention
|
Anti-human b7-h3 antibody and application thereof. Provided are an anti-human B7-H3 monoclonal an... |
|
|
Invention
|
Antibody and preparation method therefor.
Provided are an antibody and a preparation method ther... |
|
|
Invention
|
Antibody and preparation method therefor. Provided are an antibody and a preparation method there... |
|
|
Invention
|
Preparation method for bis-substituted bridging antibody-drug conjugate.
A preparation method fo... |
|
|
Invention
|
Preparation method for bis-substituted bridging antibody-drug conjugate. A preparation method for... |
|
|
Invention
|
Tgf-beta rii mutant and fusion protein thereof.
In view of the technical problem that TGF-β RH a... |
|
|
Invention
|
Tgf-β rii mutant and fusion protein thereof. In view of the technical problem that TGF-β RII and ... |
|
|
Invention
|
Anti-pd-1 antibody and stabilized preparation thereof. The present invention relates to an antibo... |
|
|
Invention
|
Anti-α-hemolysin antibody and stabilizing preparation thereof. Provided are an antibody binding t... |
|
|
Invention
|
Bispecific antibody targeting nkg2a and pd-l1, and application. On the basis of light and heavy c... |
|
|
Invention
|
Single variable domain antibody targeting human programmed death ligand 1 (pd-l1) and derivative ... |
|
|
Invention
|
Antibody against nectin-4 and application thereof.
Provided is an antibody molecule that binds t... |
|
|
Invention
|
Antibody against nectin-4 and application thereof. Provided is an antibody molecule that binds hu... |
|
|
Invention
|
Anti-st2 antibody and application thereof.
Provided are an anti-ST2 antibody or a fragment there... |
|
|
Invention
|
Anti-st2 antibody and application thereof. Provided are an anti-ST2 antibody or a fragment thereo... |
|
2020
|
Invention
|
Fully human monoclonal antibody and application thereof. A fully human monoclonal antibody or a f... |
|
|
Invention
|
Anti-human trop-2 antibody and application thereof.
The present invention provides an antibody b... |
|
|
Invention
|
Anti-human claudin 18.2 antibody and application thereof.
Embodiments of the present disclosure ... |
|
|
Invention
|
Anti-alpha-hemolysin antibody and use thereof.
Provided are an antibody that binds to Staphyloco... |
|
|
Invention
|
Recombinant anti-human pd-1 antibody and application thereof.
The present invention provides an ... |
